Filter by: Subject

Filter by: Subject

Results Per Page:

Positron emission tomography (PET) (8)
Prostate-specific membrane antigen (PSMA) (4)
SDG-03: Good health and well-being (4)
Biodistribution (3)
Infection (3)
Infection imaging (3)
PET/CT (3)
Prostate cancer (3)
68Ga (2)
68Ga-PSMA (2)
Antimicrobial peptide (AMP) (2)
Coronavirus disease 2019 (COVID-19) (2)
COVID-19 pandemic (2)
DOTA (2)
In vivo (2)
Inflammation (2)
Microemulsion (2)
NODAGA (2)
Positron emission tomography/computed tomography (PET/CT) (2)
Radiolabeling (2)
Radiotracers (2)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (2)
Ubiquicidin (2)
Zirconium-89 (2)
195mPt-cisplatinum (1)
68Ga labeling (1)
68Ga-DKFZ-PSMA-11 (1)
68Ga-HBED-CC-(Ahx)Lys-NH-CO-NH-Glu (1)
68Ga-NOTA-UBI (1)
68Ga-PSMAHBED (1)
68Ga/68Ge generator (1)
68Gallium (1)
68Ga‐PSMA‐617 (1)
68Ge/68Ga generator (1)
[213Bi]Bi-1,4,7,10- tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi8 , Met(O2 ) 11]-Substance-P (1)
[68Ga]Ga-PSMA-617-ME (1)
[68Ga]Ga1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi8 , Met(O2 ) 11]-Substance-P (1)
[89Zr]IIIB6 (1)
Africa (1)
Alpha(nu)beta(3)-integrin (1)
Angiogenesis (1)
Angiotensin-converting enzyme 2 (ACE2) (1)
Antibiotic-derived PET (1)
Antimicrobial peptides (1)
Arterial inflammation (1)
Atherosclerotic cardiovascular disease (ASCVD) (1)
Atherosclerotic cardiovascular diseases (1)
Bacteria (1)
Black South-African (BSAs) (1)
Breast cancer (1)
Cardiac implantable electronic device (CIED) (1)
Cathelicidin (1)
Cathelicidin-derived peptide (CDP1) (1)
CDP1 (1)
Cell trafficking (1)
Chemotherapy -- Research -- South Africa (1)
Cisplatin (1)
Companion diagnostic (1)
Computerized tomography (CT) (1)
Cytokine storm (1)